Vincent P. Butler

4.4k total citations · 2 hit papers
52 papers, 3.3k citations indexed

About

Vincent P. Butler is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vincent P. Butler has authored 52 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vincent P. Butler's work include Cardiac electrophysiology and arrhythmias (13 papers), Ion channel regulation and function (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Vincent P. Butler is often cited by papers focused on Cardiac electrophysiology and arrhythmias (13 papers), Ion channel regulation and function (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Vincent P. Butler collaborates with scholars based in United States, Japan and United Kingdom. Vincent P. Butler's co-authors include Edgar Haber, Thomas W. Smith, John Lindenbaum, Jnan R. Saha, Thomas W. Smith, Donald H. Schmidt, Deborah Rund, Lawrence A. Yeatman, Mark H. Mellow and Michael O. Blackstone and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Vincent P. Butler

52 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

1969 477 citations Thomas W. Smith, Vincent P. Butler et al. New England Journal of Medicine profile →
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

1981 304 citations John Lindenbaum, Deborah Rund et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent P. Butler United States	29	1.3k	910	389	354	340	52	3.3k
Warren E. C. Wacker United States	33	1.2k 0.9×	277 0.3×	428 1.1×	93 0.3×	161 0.5×	72	4.4k
E. Gerlach Germany	45	1.7k 1.3×	1.3k 1.4×	246 0.6×	586 1.7×	306 0.9×	233	6.6k
Jun Watanabe Japan	32	1.5k 1.2×	1.2k 1.3×	436 1.1×	207 0.6×	59 0.2×	313	4.3k
Derek Maclean United Kingdom	31	1.2k 0.9×	774 0.9×	177 0.5×	259 0.7×	187 0.6×	85	2.9k
Ralph E. Cutler United States	32	485 0.4×	305 0.3×	617 1.6×	81 0.2×	122 0.4×	80	3.0k
Wayne A. Colburn United States	34	1.1k 0.9×	182 0.2×	179 0.5×	162 0.5×	95 0.3×	136	3.9k
Susan M. Pond Australia	35	1.3k 1.0×	165 0.2×	290 0.7×	162 0.5×	846 2.5×	161	4.4k
Jan Olof Svensson Sweden	31	863 0.7×	864 0.9×	321 0.8×	90 0.3×	69 0.2×	80	4.7k
Akio Suzuki Japan	28	853 0.7×	442 0.5×	455 1.2×	158 0.4×	129 0.4×	281	3.2k
James J. Keirns United States	34	1.1k 0.8×	486 0.5×	249 0.6×	55 0.2×	96 0.3×	88	3.9k

Countries citing papers authored by Vincent P. Butler

Since Specialization

Citations

This map shows the geographic impact of Vincent P. Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent P. Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent P. Butler more than expected).

Fields of papers citing papers by Vincent P. Butler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent P. Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent P. Butler. The network helps show where Vincent P. Butler may publish in the future.

Co-authorship network of co-authors of Vincent P. Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent P. Butler. A scholar is included among the top collaborators of Vincent P. Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent P. Butler. Vincent P. Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butler, Vincent P., et al.. (2013). Autonomous molecular cascades for evaluation of cell surfaces. Nature Nanotechnology. 8(8). 580–586. 137 indexed citations

Akizawa, Toshifumi, et al.. (1994). Structures of Novel Bufadienolides in the Eggs of a Toad, Bufo marinus.. Chemical and Pharmaceutical Bulletin. 42(3). 754–756. 36 indexed citations

Weber, Collin J., Michele Costanzo, Jennifer Morris, et al.. (1994). Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K+-ATPase (NKA) inhibitory activity in human breast cyst fluid. Annals of Surgical Oncology. 1(4). 339–344. 5 indexed citations

Kieval, Robert S., Vincent P. Butler, Fadila Derguini, Reimar C. Bruening, & Michael R. Rosen. (1988). Cellular electrophysiologic effects of vertebrate digitalis-like substances. Journal of the American College of Cardiology. 11(3). 637–643. 26 indexed citations

Butler, Vincent P., Hymie L. Nossel, & Robert E. Canfield. (1982). [8] Immunoassay of human fibrinopeptides. Methods in enzymology on CD-ROM/Methods in enzymology. 84. 102–118. 2 indexed citations

Bremner, W F, et al.. (1982). Massive Digoxin Poisoning Treated with Fab Fragments of Digoxin-Specific Antibodies. PEDIATRICS. 70(3). 472–473. 30 indexed citations

Lindenbaum, John, et al.. (1981). Urinary excretion of reduced metabolites of digoxin. The American Journal of Medicine. 71(1). 67–74. 52 indexed citations

Lindenbaum, John, et al.. (1981). Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy. New England Journal of Medicine. 305(14). 789–794. 304 indexed citations breakdown →

Lindenbaum, John, et al.. (1976). Inhibition of Digoxin Absorption by Neomycin. Gastroenterology. 71(3). 399–404. 32 indexed citations

10.

Canfield, Robert E., Jurrien Dean, Hymie L. Nossel, Vincent P. Butler, & George D. Wilner. (1976). Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A. Biochemistry. 15(6). 1203–1209. 32 indexed citations

11.

Butler, Vincent P. & John Lindenbaum. (1975). Serum digitalis measurements in the assessment of digitalis resistance and sensitivity. The American Journal of Medicine. 58(4). 460–469. 20 indexed citations

12.

Nossel, Hymie L., et al.. (1975). Potential Use of Fibrinopeptide A Measurements in the Diagnosis and Management of Thrombosis. Thrombosis and Haemostasis. 33(3). 426–434. 21 indexed citations

13.

Butler, Vincent P., et al.. (1974). PRODUCTION AND PROPERTIES OF DIGOXIN‐SPECIFIC ANTIBODIES*. Annals of the New York Academy of Sciences. 242(1). 717–730. 6 indexed citations

14.

Butler, Vincent P., Arthur C. Fox, Alfred G. Gilman, et al.. (1974). What Should the Practicing Physician Know About Digoxin Bioavailability and How Will FDA Action Affect Him?. Circulation. 49(3). 399–400. 7 indexed citations

15.

Schmidt, Donald H., et al.. (1974). PERSISTENCE OF HAPTEN-ANTIBODY COMPLEXES IN THE CIRCULATION OF IMMUNIZED ANIMALS AFTER A SINGLE INTRAVENOUS INJECTION OF HAPTEN. The Journal of Experimental Medicine. 139(2). 278–294. 36 indexed citations

16.

Butler, Vincent P., et al.. (1973). Reversal of the Pharmacological and Toxic Effects of Cardiac Glycosides by Specific Antibodies. Pharmacological Reviews. 25(2). 239–248. 5 indexed citations

17.

Gardner, Jerry D., et al.. (1973). Effects of Digoxin-Specific Antibodies on Accumulation and Binding of Digoxin by Human Erythrocytes. Journal of Clinical Investigation. 52(8). 1820–1833. 40 indexed citations

18.

Schmidt, Donald H. & Vincent P. Butler. (1971). Immunological protection against digoxin toxicity. Journal of Clinical Investigation. 50(4). 866–871. 51 indexed citations

19.

Lindenbaum, John, Mark H. Mellow, Michael O. Blackstone, & Vincent P. Butler. (1971). Variation in Biologic Availability of Digoxin from Four Preparations. New England Journal of Medicine. 285(24). 1344–1347. 203 indexed citations

20.

Schmidt, Donald H. & Vincent P. Butler. (1971). Reversal of Digoxin Toxicity with Specific Antibodies. Journal of Clinical Investigation. 50(8). 1738–1744. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact